Petra Steinacker

7.7k total citations
107 papers, 4.4k citations indexed

About

Petra Steinacker is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Petra Steinacker has authored 107 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Neurology, 50 papers in Molecular Biology and 39 papers in Physiology. Recurrent topics in Petra Steinacker's work include Alzheimer's disease research and treatments (38 papers), Parkinson's Disease Mechanisms and Treatments (33 papers) and Prion Diseases and Protein Misfolding (31 papers). Petra Steinacker is often cited by papers focused on Alzheimer's disease research and treatments (38 papers), Parkinson's Disease Mechanisms and Treatments (33 papers) and Prion Diseases and Protein Misfolding (31 papers). Petra Steinacker collaborates with scholars based in Germany, Italy and United States. Petra Steinacker's co-authors include Markus Otto, Patrick Oeckl, Albert C. Ludolph, Jens Wiltfang, Steffen Halbgebauer, Christine A. F. Von Arnim, Brit Mollenhauer, S. Poser, Lukas Cepek and Stefan Lehnert and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Brain.

In The Last Decade

Petra Steinacker

106 papers receiving 4.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Petra Steinacker 1.9k 1.8k 1.7k 900 851 107 4.4k
Luisa Benussi 1.7k 0.9× 1.3k 0.7× 2.3k 1.3× 726 0.8× 953 1.1× 138 5.0k
Amanda Heslegrave 1.3k 0.7× 1.2k 0.7× 1.6k 0.9× 751 0.8× 996 1.2× 139 4.3k
Patrick Oeckl 1.2k 0.6× 1.3k 0.8× 1.1k 0.6× 525 0.6× 634 0.7× 86 3.2k
Takahiko Tokuda 2.3k 1.2× 3.3k 1.9× 2.5k 1.5× 629 0.7× 970 1.1× 171 6.9k
Yoshio Hashizume 1.9k 1.0× 2.3k 1.3× 1.0k 0.6× 290 0.3× 1.2k 1.4× 232 5.5k
Chiara Fenoglio 2.1k 1.1× 1.2k 0.7× 1.9k 1.1× 593 0.7× 1.6k 1.9× 172 5.7k
Alexander Gerhard 1.5k 0.7× 2.2k 1.2× 1.7k 1.0× 709 0.8× 2.3k 2.7× 86 5.8k
Sanna‐Kaisa Herukka 889 0.5× 891 0.5× 1.9k 1.1× 1.3k 1.5× 636 0.7× 106 3.5k
Annachiara Cagnin 749 0.4× 1.2k 0.6× 1.1k 0.6× 512 0.6× 1.3k 1.6× 59 3.5k
Erin H. Norris 1.1k 0.5× 1.6k 0.9× 1.7k 1.0× 197 0.2× 1.3k 1.5× 58 4.2k

Countries citing papers authored by Petra Steinacker

Since Specialization
Citations

This map shows the geographic impact of Petra Steinacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Steinacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Steinacker more than expected).

Fields of papers citing papers by Petra Steinacker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Steinacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Steinacker. The network helps show where Petra Steinacker may publish in the future.

Co-authorship network of co-authors of Petra Steinacker

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Steinacker. A scholar is included among the top collaborators of Petra Steinacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Steinacker. Petra Steinacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seifert, Michael, et al.. (2024). Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis. Brain Communications. 6(5). fcae288–fcae288. 5 indexed citations
2.
Barba, Lorenzo, Christoph Vollmuth, Steffen Halbgebauer, et al.. (2024). Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation. European Journal of Neurology. 32(1). e16581–e16581. 3 indexed citations
3.
Barba, Lorenzo, Giovanni Bellomo, Patrick Oeckl, et al.. (2024). CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases. Journal of the Neurological Sciences. 462. 123059–123059. 2 indexed citations
4.
Vollmuth, Christoph, Cornelia Fießler, Felipe A. Montellano, et al.. (2024). Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke. European Stroke Journal. 9(3). 751–762. 4 indexed citations
5.
Barba, Lorenzo, Lorenzo Gaetani, Samir Abu‐Rumeileh, et al.. (2024). CSF synaptic biomarkers and cognitive impairment in multiple sclerosis. Journal of Neurology. 272(1). 85–85. 1 indexed citations
6.
Witzel, Simon, Jeffrey Statland, Petra Steinacker, et al.. (2023). Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis—insights from a completed randomized controlled trial with rasagiline. European Journal of Neurology. 31(3). e16154–e16154. 5 indexed citations
7.
Barba, Lorenzo, Samir Abu‐Rumeileh, Steffen Halbgebauer, et al.. (2023). CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease. Neurology. 101(1). e50–e62. 24 indexed citations
8.
Abu‐Rumeileh, Samir, Steffen Halbgebauer, Lorenzo Barba, et al.. (2023). High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease. Annals of Clinical and Translational Neurology. 10(10). 1904–1909. 7 indexed citations
9.
Abu‐Rumeileh, Samir, Lorenzo Barba, Matthias Bache, et al.. (2023). Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy. Annals of Clinical and Translational Neurology. 10(10). 1924–1930. 6 indexed citations
10.
Oeckl, Patrick, Sarah Anderl‐Straub, Christine A. F. Von Arnim, et al.. (2022). Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion. Journal of Neurology Neurosurgery & Psychiatry. 93(6). 659–667. 64 indexed citations
11.
Barba, Lorenzo, Steffen Halbgebauer, Federico Paolini Paoletti, et al.. (2022). Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease. International Journal of Molecular Sciences. 23(13). 6922–6922. 7 indexed citations
12.
Otto, Markus, György A. Homola, Petra Steinacker, et al.. (2022). Serum Glial Fibrillary Acidic Protein Indicates Memory Impairment in Patients with Chronic Heart Failure. ESC Heart Failure. 9(4). 2626–2634. 16 indexed citations
13.
Massa, Federico, et al.. (2021). Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration. Journal of Neural Transmission. 129(2). 207–230. 60 indexed citations
14.
Witzel, Simon, Felix Frauhammer, Petra Steinacker, et al.. (2021). Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials. Translational Neurodegeneration. 10(1). 31–31. 20 indexed citations
15.
Steinacker, Petra, MHD Rami Al Shweiki, Patrick Oeckl, et al.. (2021). Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder. Journal of Psychiatric Research. 144. 54–58. 48 indexed citations
16.
Shweiki, MHD Rami Al, Patrick Oeckl, Petra Steinacker, et al.. (2020). S-ketamine induces acute changes in the proteome of the mouse amygdala. Journal of Proteomics. 216. 103679–103679. 7 indexed citations
17.
Shweiki, MHD Rami Al, Patrick Oeckl, Petra Steinacker, et al.. (2020). Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder. Translational Psychiatry. 10(1). 144–144. 32 indexed citations
18.
Belz, Michael, Jonathan Vogelgsang, Petra Steinacker, et al.. (2019). Serum neurofilament light chain (NFL) remains unchanged during electroconvulsive therapy. The World Journal of Biological Psychiatry. 21(2). 148–154. 18 indexed citations
19.
Halbgebauer, Steffen, et al.. (2016). Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins. Movement Disorders. 31(6). 848–860. 47 indexed citations
20.
Jesse, Sarah, Petra Steinacker, Stefan Lehnert, et al.. (2009). Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review. CNS Neuroscience & Therapeutics. 15(2). 157–182. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luisa Benussi Breakdown of academic impact, for papers by Amanda Heslegrave Breakdown of academic impact, for papers by Patrick Oeckl Breakdown of academic impact, for papers by Takahiko Tokuda Breakdown of academic impact, for papers by Yoshio Hashizume Breakdown of academic impact, for papers by Chiara Fenoglio Breakdown of academic impact, for papers by Alexander Gerhard Breakdown of academic impact, for papers by Sanna‐Kaisa Herukka Breakdown of academic impact, for papers by Annachiara Cagnin Breakdown of academic impact, for papers by Erin H. Norris
Rankless by CCL
2026